Psychedelic Drugs Draw Some Investor Attention - And Much Skepticism

A few entrepreneurs and investors see opportunity for novel mental-health treatments, but traditional health-care investors say it is too earlyPsychedelic substances are gaining legitimacy as a treatment for mental illnesses, prompting a handful of entrepreneurs and venture-capital investors to look for business opportunities in the nascent sector.